Schizophrenia Clinical Trial
— IRM-COGOfficial title:
Exploration of Neural Bases in Social Cognition
An impairment in social cognition in schizophrenia could account for the severe professional
and social difficulties among patients. Social cognition is the way the social world is
understood, perceived and interpreted. It includes all the process than enable oneself to
interact with another person, namely emotion perception and processing, theory of mind
(ToM), social perception, social knowledge and attributional style. Since these process are
interconnected, social cognition should be investigated through ecological tasks which
activate all of them together. Developing a social cognition ecological task, then testing
the reproducibility of the functional magnetic resonance imagery (fMRI) BOLD signal is the
main objective of this study. The secondary objective is to seek a functional deficit among
the neural network of social cognition in patients with schizophrenia compared with healthy
subjects.
Forty healthy subjects, aged from 18 to 60 years old, who have given a written consent, will
be included. The social cognition paradigm will be developed and the fMRI activations will
be compared to those of a visual cartoon based task, known to turn on the neural network of
ToM. BOLD signal variations at a high statistical correction ratio (p<0.05) will be explored
and compared to the signal of a second fMRI, made on the same 20 healthy subjects one month
later, to test reproducibility (% of identical activated voxels during the 2 fMRI, p<0.05).
Twenty matched patients with schizophrenia (DSM-IV-R), aged from 18 to 60 will be included
to test the secondary objective. We make the hypothesis of a fMRI functional alteration in
the cerebral network involved in social cognition, especially in the medial prefrontal
cortex, among patients compared with healthy subjects.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | September 2015 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Subjects aged from 18 to 60 years old - who have signed a consent and, if there is one, whose legal representant has signed a consent 1)For healthy subjects: - without any psychiatric affection (Mini International Neuropsychiatric Interview) 2)For patients - meeting the DSM-IV-R criteria for schizophrenia or schizoaffective disorder Exclusion Criteria: - pregnant woman - neurological affection - medical objection to Magnetic Resonance Imagery (MRI) |
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
France | Centre Hospitalier Universitaire | Caen | Normandy |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Caen |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Developing a social cognition ecological task, then testing the reproducibility of the functional magnetic resonance imagery (fMRI) BOLD signal | The social cognition paradigm will be developed and the fMRI activations will be compared to those of a visual cartoon based task, known to turn on the neural network of ToM. BOLD signal variations at a high statistical correction ratio (p<0.05) will be explored and compared to the signal of a second fMRI, made on the same 20 healthy subjects one month later, to test reproducibility (% of identical activated voxels during the 2 fMRI, p<0.05) | Day 1 for individual analysis. Up to 24 months for group analysis. | No |
Secondary | Identifying a functional deficit among the neural network of social cognition in patients with schizophrenia compared with healthy subjects. | Using the previous social cognition ecological task, BOLD signal variations at a high statistical correction ratio (p<0.05) of 20 patients with schizophrenia will be compared to those of 20 matched healthy subjects. | Day 1 for individual analysis. Up to 24 months for group analysis. | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |